PER 0.00% 8.0¢ percheron therapeutics limited

ATL1102 Blockbuster drug in 2020 and a Coy maker., page-4

  1. 13,783 Posts.
    lightbulb Created with Sketch. 1464
    so what I’m saying in short:
    Sarepta have 2 drugs for DMD and approved by the FDA but have no “Clinical Benefit”..,and further more they have 4 years that they do have CB..MC $6 billion and rising

    Anp has a drug for DMD safe and Tolerable and shows Clinical Benefit (CB) Mc $35 mill

    But not for long...$$$



 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.000(0.00%)
Mkt cap ! $84.79M
Open High Low Value Volume
8.1¢ 8.2¢ 7.9¢ $152.3K 1.896M

Buyers (Bids)

No. Vol. Price($)
2 8319 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.6¢ 18027 1
View Market Depth
Last trade - 15.44pm 15/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.